Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
2029-03-30
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare efficacy of two different resection extension
in patients with resectable recurrent nasopharyngeal carcinoma after induction chemotherapy.
The main question it aims to answer is that whether tumor regress areas after induction
chemotherapy required complete resection. Patients will be randomly assigned to receive
reduced-target resection or full-target resection after induction chemotherapy. Researchers
will compare these two groups to see if the efficacy of reduced-target resection is not
inferior to full-target resection.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Fifth Affiliated Hospital of Guangzhou Medical University First Affiliated Hospital, Sun Yat-Sen University First People's Hospital of Foshan Nanfang Hospital of Southern Medical University Zhongshan People's Hospital, Guangdong, China